Functional domains of APOBEC3G required for antiviral activity

Journal of Cellular Biochemistry

Volumn 92, Issue 3, 2004, Pages 560-572

  Li, Jinliang ^a   Potash, Mary Jane ^a   Volsky, David J ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

APOBEC3G; HIV 1; Innate immunity

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; COMPLEMENTARY DNA; PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS RNA; CEM15 PROTEIN, HUMAN; DEAMINASE; REPRESSOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELLULAR DISTRIBUTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRION; VIRUS REPLICATION; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE PRODUCTS, VIF; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPRECIPITATION; MUTATION; NUCLEOSIDE DEAMINASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTION; RNA, VIRAL; VIRION;

EID: 7444268898     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20082     Document Type: Article

References (29)

1. Accola MA, Öhagen Å, Göttlinger HG. 2000. Isolation of human immunodeficiency virus type 1 cores: Retention of Vpr in the absence of p6gag. J Virol 74:6198-6202.
2. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284-291.
3. Chowdhury IH, Chao W, Potash MJ, Sova P, Gendelman HE, Volsky DJ. 1996. Vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J Virol 70:5336-5345.
4. Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
5. Gabuzda DH, Lawrence K, Langhoff E, Terwilliger E, Dorfman T, Haseltine WA, Sodroski J. 1992. Role of Vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol 66:6489-6495.
6. Gaddis NC, Chertova E, Sheehy AM, Henderson LE, Malim MH. 2003. Comprehensive investigation of the molecular defect in Vif-deficient human immunodeficiency virus type 1 virions. J Virol 77:5810-5820.
7. Goff SP. 1990. Retroviral reverse transcriptase: Synthesis, structure, and function. J Acquir Immune Defic Syndr 3:817-831.
8. Goncalves J, Jallepalli P, Gabuzda DH. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J Virol 68:704-712.
9. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
10. Hoglund S, Ohagen A, Lawrence K, Gabuzda D. 1994. Role of Vif during packing of the core of HIV-1. Virology 201:349-355.
11. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N. 2002. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79:285-296.
12. Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K. 2003. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G. CEM15, a cellular inhibitor of virus infectivity. J Virol 77:11398-11407.
13. Kimpton J, Emerman M. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated b-galactosidase gene. J Virol 66:2232-2239.
14. Kotler M, Simm M, Zhao YS, Sova P, Chao W, Ohnona SF, Roller R, Krachmarov C, Potash MJ, Volsky DJ. 1997. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro. J Virol 71:5774-5781.
15. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112.
16. MacGinnitie AJ, Anant S, Davidson NO. 1995. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem 270:14768-14775.
17. Madani N, Kabat D. 1998. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol 72:10251-10255.
18. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
19. Mariani R, Chen D, Schröfelbauer B, Navarro F, König R, Bollman B, Münk C, Nymark-McMahon H, Landau NR. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31.
20. Marin M, Rose KM, Kozak SL, Kabat D. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403.
21. Oberste MS, Gonda MA. 1992. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6:95-102.
22. Sakai H, Shibata R, Sakuragi J-I, Sakuragi S, Kawamura M, Adachi A. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol 67:1663-1666.
23. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
24. Sheehy AM, Gaddis NC, Malim MH. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407.
25. Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ. 1995. Aberrant gag protein composition of a human immunodeficiency virus type 1 Vif mutant produced in primary lymphocytes. J Virol 69:4582-4586.
26. Simon JHM, Miller DL, Fouchier RAM, Malim MH. 1998. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virology 248:182-187.
27. von Schwedler U, Song J, Aiken C, Trono D. 1993. Vif is crucial for human immunodeficiency virus type 1 pro-viral DNA synthesis in infected cells. J Virol 67:4945-4955.
28. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. 1990. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
29. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.